Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

NCT02670551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder
Depression

Interventions

DRUG: Cariprazine
DRUG: Placebo

Sponsor

Forest Laboratories